Lumen Bioscience, Inc.

Quick facts

Phase 2 pipeline

• LMN-101
• LMN-201

Phase 1 pipeline

• LMN-201 Anti-toxin B VHH-1
• LMN-201 Anti-toxin B VHH-1, VHH-2, VHH-3
• LMN-201 Anti-toxin B VHH-2
• LMN-201 Anti-toxin B VHH-3
• LMN-301
• LMN-401

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Lumen Bioscience, Inc. portfolio CI brief
• Lumen Bioscience, Inc. pipeline updates RSS